Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $277.74 million. The enterprise value is $284.39 million.
| Market Cap | 277.74M |
| Enterprise Value | 284.39M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 8.62 million shares outstanding. The number of shares has increased by 4.71% in one year.
| Shares Outstanding | 8.62M |
| Shares Change (YoY) | +4.71% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 60.59% |
| Owned by Institutions (%) | 8.41% |
| Float | 3.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.27 |
| Forward PS | 3.49 |
| PB Ratio | 6.20 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.38 |
| EV / EBITDA | 1,492.18 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.38 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 61.87 |
| Debt / FCF | n/a |
| Interest Coverage | -8.04 |
Financial Efficiency
Return on equity (ROE) is -10.00% and return on invested capital (ROIC) is -13.54%.
| Return on Equity (ROE) | -10.00% |
| Return on Assets (ROA) | -6.40% |
| Return on Capital (ROIC) | -13.54% |
| Revenue Per Employee | $607,382 |
| Profits Per Employee | -$40,217 |
| Employee Count | 107 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 1.90 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.73% in the last 52 weeks. The beta is 1.63, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (1Y) | 1.63 |
| 52-Week Price Change | -24.73% |
| 50-Day Moving Average | 35.94 |
| 200-Day Moving Average | 35.71 |
| Relative Strength Index (RSI) | 37.51 |
| Average Volume (30 Days) | 13,461 |
Short Selling Information
The latest short interest is 140,254, so 1.63% of the outstanding shares have been sold short.
| Short Interest | 140,254 |
| Short Previous Month | 142,611 |
| Short % of Shares Out | 1.63% |
| Short % of Float | 4.06% |
| Short Ratio (days to cover) | 10.80 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $64.99 million and -$4.30 million in losses. Loss per share was -$0.52.
| Revenue | 64.99M |
| Gross Profit | 57.14M |
| Operating Income | -7.67M |
| Pretax Income | -4.30M |
| Net Income | -4.30M |
| EBITDA | 190,584 |
| EBIT | -3.83M |
| Loss Per Share | -$0.52 |
Balance Sheet
The company has $5.15 million in cash and $11.79 million in debt, giving a net cash position of -$6.64 million or -$0.77 per share.
| Cash & Cash Equivalents | 5.15M |
| Total Debt | 11.79M |
| Net Cash | -6.64M |
| Net Cash Per Share | -$0.77 |
| Equity / Book Value | 44.83M |
| Book Value Per Share | 5.20 |
| Working Capital | 5.24M |
Cash Flow
In the last 12 months, operating cash flow was -$3.25 million and capital expenditures -$264,596, giving a free cash flow of -$3.51 million.
| Operating Cash Flow | -3.25M |
| Capital Expenditures | -264,596 |
| Free Cash Flow | -3.51M |
| FCF Per Share | -$0.42 |
Margins
Gross margin is 87.92%, with operating and profit margins of -11.79% and -6.62%.
| Gross Margin | 87.92% |
| Operating Margin | -11.79% |
| Pretax Margin | -6.62% |
| Profit Margin | -6.62% |
| EBITDA Margin | 0.29% |
| EBIT Margin | -5.89% |
| FCF Margin | -5.40% |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.71% |
| Shareholder Yield | -4.71% |
| Earnings Yield | -1.55% |
| FCF Yield | -1.26% |
Analyst Forecast
The average price target for Sanara MedTech is $51.50, which is 59.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $51.50 |
| Price Target Difference | 59.89% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
Sanara MedTech has an Altman Z-Score of 5.95 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.95 |
| Piotroski F-Score | 3 |